Pharm Neuro IV Flashcards
Chlorpromazine
Typical antipsychotic D2 antagonist low potency Schizophrenia (+ symp.) psychosis, acute mania, Tourette syndrome Side effects: ANS (dry mouth), sedation, hypotension
Haloperidol
Typical antipsychotics D2 antagonist High potency Schizophrenia (+ symp.), Huntington’s Side effects: EPS tardive dyskinesia Neuroleptic malignant syndrome
Clozapine
Atypical antipsychotics D2/5HT2A antagonist (low ratio) Schizophrenia (- symp) SE: weight gain, *agranulocytosis*, seizures, prolonged QT
Olanzapine
Atypical antipsychotics D2/5HT2A antagonist (low ratio) Schizophrenia (- symp) SE: weight gain, prolonged QT
Quetiapine
Atypical antipsychotics D2/5HT2A antagonist (low ratio) Schizophrenia: (- symp) SE: weight gain, prolonged QT, some sedation
Risperidone
Atypical antipsychotics D2/5HT2A antagonist (low ratio) Schizophrenia (- symp) SE: increased prolactin (lactation and gynecomastia) irregular menstruation and fertility issues, DM type II, prolonged QT
Aripiprazole
Atypical antipsychotics D2 and 5HT1A Partial agonist, 5HT2A antagonist high potency Schizophrenia (- symp) SE: weight gain, headache, anxiety, insomnia, nausea, constipation, lightheadedness
Ziprasidone
Atypical antipsychotics D2/5HT2A antagonist (low ratio)
Paroxetine
SSRI Block SERT SE: sedation, constipation, weight gain, dry mouth, serotonin syndrome, SIADH, sexual dysfunction, withdrawal symptoms (
Sertraline
SSRI Block SERT SE: *GI distress*, activation insomnia, constipation, dry mouth, weight gain, serotonin syndrome, SIADH, sexual dysfunction, withdraw symptoms (
Citalopram
SSRI Block SERT SE: fewest of the SSRIs
Escitralopram
SSRI Block SERT SE: fewest of the SSRIs
Bupropion
NE DA reuptake inhibitor (NDRI) Depression (Wellbutrin), smoking cessation (Zyban) SE: insomnia/agitation, stimulant effects, headache, *seizures at high dose* no sedation, no addiction, no tolerance and no sexual SE no interaction with EtOH
Venlafaxine
SNRI SERT and NET blocker Depression, anxeity, panic, PTSD SE: Hypertension, anxeity, nausea, withdrawal symptoms, sexual dys., sedation
Duloxetine
SNRI SERT and NET blocker Depression, Diabetic peripheral neuropathy SE: Hypertension, anxeity, nausea, withdrawal symptoms, sexual dys., sedation
Trazodone
Mixed serotonin receptor and alpha 1 receptor blocker Insomnia, High doses for depression SE: sedation, nausea, priapism (trazo*bone*), postural hypotension
Mirtazapine
Alpha-2 adrenergic antagonist increase release of NE and 5HT 5HT2 and 3 receptor antagonist depression, insomnia SE: sedation, increase appetite, weight gain, dry mouth
Amitriptyline
TCADs NET/SERT reuptake block Major depression, peripheral neuropathy, chronic pain, migraine prophylaxis SE: Sedation, antimuscarinic (Amitriptyline >Desipramine), orthostatic hypotension, Convulsions, Coma, Cardiotoxicity (arrhythmias), respiratory depression
Nortriptyline
TCADs NET/SERT reuptake block Major depression, peripheral neuropathy, chronic pain, migraine prophylaxis SE: Sedation, antimuscarinic, orthostatic hypotension, Convulsions, Coma, Cardiotoxicity (arrhythmias), respiratory depression
Imipramine
TCADs NET/SERT reuptake block Major depression, enuresis SE: Sedation, antimuscarinic, orthostatic hypotension, Convulsions, Coma, Cardiotoxicity (arrhythmias), respiratory depression
Desipramine
TCADs NET reuptake block Major depression, peripheral neuropathy, chronic pain, migraine prophylaxis SE: Sedation, antimuscarinic (Amitriptyline >Desipramine), orthostatic hypotension, Convulsions, Coma, Cardiotoxicity (arrhythmias), respiratory depression
Clomipramine
TCADs (NET)/SERT reuptake block Major depression, OCD, peripheral neuropathy, chronic pain, migraine prophylaxis SE: *Sedation*, antimuscarinic , orthostatic hypotension, Convulsions, Coma, Cardiotoxicity (arrhythmias), respiratory depression
Phenelzine
MAOI Atypical depression, anxeity SE: Hypertensive crisis (tyramine), CNS stimulation, Serotonin syndrome
Fluoxetine
SSRI Block SERT SE: Hypertension, anxeity, nausea, withdrawal symptoms (lower risk with fluox), sexual dys., sedation
Selegiline
MAOI Parkinson’s SE: Hypertensive crisis (tyramine), CNS stimulation, Serotonin syndrome
Lithium
mechanism unknown (inhibition of phosphoinositol cascade) Mood stabilizer for bipolar blocks relapse and acute manic events SE: narrow therapeutic index (monitoring) LMNOP Movement (tremor) Nephrogenic Diabetes Insipitus O-hypOthyroid Pregnancy problems (Ebstein anomaly) polyuria (diabetes insipitus),
Carbamazepine
Antimanic agent
Alprazolam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening short acting, high potency acute management of anxiety. (situational anxiety) ,SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Flurazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening Anxiety, spasticity, detox, night terrors, sleepwalking, general anesthetic (amnesia, muscle relaxant), insomnia SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Diazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening longer half life acute management of anxiety. (situational anxiety) SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Oxazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening; short acting anxiety, insomnia, withdraw from EtOH SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Triazolam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening; short acting Insomnia SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Lorazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening short half life, high potency acute management of anxiety. (situational anxiety) good for elderly SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Midazolam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening; short acting anesthesia (adjunct), anxiety, insomnia SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Temazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening insomnia, anxiolytic, anticonvulsant, muscle relaxant SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Flumazenil
Benzodiazepine receptor ANTagonist used for OD of Benzo
Zolpidem
Non-BDZ Activate BZ1 subtype of GABA receptor Insomnia SE: Ataxia, headache, confusion less dependence risk, less amnesia
Eszopiclone
Non-BDZ Activate BZ1 subtype of GABA receptor Insomnia SE: Ataxia, headache, confusion less dependence risk, less amnesia
Zaleplon
Non-BDZ Activate BZ1 subtype of GABA receptor (GABA Cl- channel) Insomnia SE: Ataxia, headache, confusion less dependence risk, less amnesia
Pentobarbital
Barbiturates increase *duration* of GABA CL- channel opening Anxiety, seizures, insomnia, anesthesia (thiopental) SE: Respiratory and CV depression! CNS depression (worse w/ EtOH), dependence, DDI (P-450 inducer)